Cite Filings / ORKA / 0001950047-26-010266
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Oruka Therapeutics, Inc. · Filed 2026-10-15 · Acc 0001950047-26-010266

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-11-02 144 Sale of Securities
  • 2026-10-20 4 General Counsel sold 9,000 shares at an average $78.53 ($706,735)
  • 2026-10-15 144 Sale of Securities
  • 2026-10-15 4 Chief Medical Officer sold 7,000 shares at an average $74.81 ($523,648)
  • 2026-10-13 144 Sale of Securities
  • 2026-10-13 4 Senior Vice President, Finance sold 9,999 shares at an average $80.60 ($805,889)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…